Search
Get in touch!
Linkedin X-twitter Envelope

Norges Bank 2025 Investment Conference: What Makes A Great Company?

Once again, the good people at Norges Bank have brought together a very interesting group of speakers to their 2025 Annual Investment Conference, titled “What Makes a Great Company?”

Speakers include some of the world’s leading CEOs, investors, and academics to explore the essential qualities behind enduring corporate excellence, including leaders from Goldman Sachs, Novo Nordisk, Otis, Ferrari, Nasdaq, and investment firms, offering a rare, multifaceted perspective on what sets truly great companies apart in an era of rapid change and uncertainty.

Here are the key takeaways:

  • Enduring Purpose and Strong Culture Are Fundamental: Across all speakers, a clear, long-term purpose and a strong, values-driven culture were repeatedly highlighted as the foundation of great companies. For example, Goldman Sachs attributes its 156-year longevity to a culture rooted in partnership, integrity, client service, and excellence, continuously investing in these values to adapt and thrive.
  • Relentless Innovation and Adaptability: Great companies don’t just preserve their core-they relentlessly innovate and adapt. Novo Nordisk’s transformation of diabetes and obesity care, Otis’s integration of AI and IoT into elevator services, and Ferrari’s blend of tradition with cutting-edge technology all illustrate the importance of continuous, purpose-driven innovation to stay ahead in changing markets.
  • Operational Excellence and Discipline Drive Sustainable Results: Operational discipline, clear business models, and a focus on execution underpin sustainable growth. Otis, for example, credits its long-term success to a disciplined “flywheel” model, operational rigor, and a focus on customer-centric service, resulting in steady growth and high customer retention over decades.
  • Leadership, Talent, and Culture of Learning: Leadership that fosters open communication, humility, and a learning mindset is vital. Ferrari’s CEO emphasized direct engagement at all levels, humility, and a willingness to challenge the status quo, while Nasdaq’s Adena Friedman stressed the need for “humble confidence” and constant learning in a fast-changing technological landscape.
  • Long-Term Orientation and Resilience: Both investors and executives agreed that long-term thinking-rather than chasing short-term gains-is crucial. Leading investors highlighted the importance of finding companies with durable competitive advantages, barriers to entry, and resilient business models, and then holding them for the long haul to realize true value.

Click here to go to the external source.

Share the news

Disclaimer of liability

The above has been prepared by Børsgade ApS for information purposes and cannot be regarded as a solicitation or recommendation to buy or sell any security. Nor can the information etc. be regarded as recommendations or advice of a legal, accounting or tax nature. Børsgade cannot be held liable for losses caused by customers’/users’ actions – or lack thereof – based on the information in the above. We have made every effort to ensure that the information in the above is complete and accurate, but cannot guarantee this and accept no liability for errors or omissions.

Readers are advised that investing may involve a risk of loss that cannot be determined in advance, and that past performance and price development cannot be used as a reliable indicator of future performance and price development. For further information please contact info@borsgade.dk

You might also find this interesting:

Warren Buffett: Lessons from the Oracle of Omaha

June 12, 2025

In this special celebratory episode from The Investor’s Podcast, host William Green shares his personal observations from attending the annual shareholder meeting in Omaha where the announcement was made, describing it as the most joyful meeting he’s ever attended.

The episode features powerful highlights from Green’s previous conversations with legendary investors including Joel Greenblatt, Nick Sleep, Thomas Russo, Chris Davis, Chuck Akre, and Christopher Bloomstran, all discussing Buffett’s profound influence on their investment approaches.

Chris Davis: Navigating Todays Turbulent Markets With Bill Miller

June 6, 2025

Two legendary portfolio managers, Chris Davis and Bill Miller, engaged in a comprehensive discussion about navigating today’s volatile investment landscape, drawing from their combined decades of experience managing billions in assets.

The conversation, structured around nine key topics, covers everything from investment temperament and market volatility to emerging technologies and geopolitical challenges. Miller, famous for outperforming the S&P 500 for 15 consecutive years while managing the Legg Mason Value Trust, and Davis share insights on stewardship, patience, and contrarian investing approaches. The discussion emphasizes the importance of long-term thinking, adaptability, and maintaining perspective during uncertain times.

Michael Mauboussin: Drawdowns Are The Unavoidable Cost of Long-Term Investing

June 6, 2025

Michael Mauboussin from Morgan Stanley Investment Management have published a comprehensive analysis examining stock market drawdowns and recovery patterns from 1985 to 2024. The research reveals that even the most successful investments experience severe price declines, with the median stock suffering an 85% drawdown that takes 2.5 years from peak to trough.

The study analyzed over 6,500 companies and found that more than half never recover to their previous highs. Michael’s work demonstrates that large drawdowns are an inevitable feature of equity investing, affecting individual stocks, mutual funds, and even portfolios with perfect foresight.

Thomas Gayner: My Current Take on Novo Nordisk

June 6, 2025

In his interview, Tom Gayner, CEO of Markel Group, reflects on investment principles shaped by Warren Buffett and Charlie Munger, and offers a detailed assessment of Novo Nordisk. Gayner praises Novo Nordisk for its business quality, global leadership in diabetes treatment, and strong growth trajectory. He credits the company’s disciplined management and innovation in pharmaceuticals as exemplary, aligning with his own standards of long-term value creation.